Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
Congress Bars EPA from accepting human pesticide data Thu, 28 Jul 2005 Thank you Senator Barbara Boxer and Representative Hilda Solis for leading the charge to stop the Environmental Protection Agency in its tracks. The EPA was formulating rules that would have oveturened the Nuremberg Code prohibition against using poisonous…
FDA Requires Bar Codes on Drugs-IG resigns Date: Fri, 14 Mar 2003 On a positive note, the FDA has finally come up with a proposal to cut medical errors in hospitals. Drug manufacturers will be required to put drug bar codes on every prescription drug to protect patients from fatal…
Wed, 04 May 2005 Researchers Tested AIDS Drugs on Children, Associated Press On March 10, 2004, The Alliance for Human Research Protection filed a complaint with the FDA and the federal Office of Human Research Protection about a series of AIDS drug experiments conducted on New York City children in…
Follow the Money / Can the Institute of Medicine Review the FDA? Wed, 6 Apr 2005 A letter to the editor published in Nature Medicine by Dr. Bernard Carroll, a past chairman of the FDA Advisory Committee for Psychotropic Drugs, and past chairman of the Department of Psychiatry at Duke…
National Institue AIDS Research–Professional Women Describe Sex Harassment – Conduct Unbecoming Mon, 11 Apr 2005 Just when the NIH announced that it was in the clear – citing a report issued (April 6) by a panel of the Institute of Medicine "exonerating" NIH and rejecting the allegations by Dr. Jonathan…
’91 Merck Memo Warned of Mercury in Baby Vaccines – LAT Tue, 8 Feb 2005 The Los Angeles Times reports that a 1991 internal Merck memo obtained from a whistleblower by James Moody, a Washington lawyer who works with parent groups on vaccine safety issues, provides the “first hard evidence…
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
FDA's Dr. Steven Galson, like his predecessor who now occupies a position in the Commissioner's office, demonstrates disconnectedness from reality, much like Nero who fiddled while Rome burned…
Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.
The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex.
A report by the Institute of Medicine is sharply critical of FDA’s drug safety monitoring system: "The report’s conclusions are striking and often damning – particularly when discussing the agency’s Center for Drug Evaluation and Research, known as C.D.E.R."
